Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity

European Journal of Oncology Nursing

Volumn 16, Issue 3, 2012, Pages 270-275

  Can, Gulbeyaz ^a   Aydiner, Adnan ^a   Cavdar, Ikbal ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Frozen gloves and socks; Nail toxicity; Predictors; Taxane

Indexed keywords

ANTINEOPLASTIC AGENT; TAXOID;

ADULT; AGED; ARTICLE; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CHI SQUARE DISTRIBUTION; CLOTHING; CROSS-SECTIONAL STUDY; CRYOTHERAPY; FEMALE; FREEZING; HUMAN; INSTRUMENTATION; INTERVENTION STUDY; LUNG TUMOR; MALE; MIDDLE AGED; NAIL DISEASE; ONYCHOLYSIS; OVARY TUMOR; PROSPECTIVE STUDY; PROTECTIVE CLOTHING; QUALITY OF LIFE; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CHI-SQUARE DISTRIBUTION; CLOTHING; CROSS-SECTIONAL STUDIES; CRYOTHERAPY; FEMALE; FREEZING; GLOVES, PROTECTIVE; HUMANS; INTERVENTION STUDIES; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NAIL DISEASES; ONYCHOLYSIS; OVARIAN NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; RISK FACTORS; TAXOIDS; TREATMENT OUTCOME; TURKEY;

EID: 84861339925     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2011.06.007     Document Type: Article

References (17)

1. Almagro M., Del Pozo J., Garcia J., Vasquez A., Fonseca E. Nail alterations secondary to pactitaxel therapy. European Journal of Dermatology 2000, 10(2):146-147.
2. Baker J., Ajani J., Scotté F., Winther D., Martin M., Aapro M.S., Von Minckwitz G. Docetaxel-related side effects and their management. European Journal of Oncology Nursing 2009, 13(1):49-59.
3. Drake R.D., Lin W.M., King M., Farrar D., Miller D.S., Coleman R.L. Oral dexamethasone attenuates doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies. Gynecologic Oncology 2004, 94(2):320-324.
4. Gilbar P., Hain A., Peereboom V.M. Nail toxicity induced by cancer chemotherapy. Journal of Oncology Pharmacy Practice 2009, 15(3):143-155.
5. Hackbarth M., Haas N., Fotopoulou C., Lichtenegger W., Sehouli J. Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study. Support Care Cancer 2008, 16(3):267-273.
6. Hong J., Park S.H., Choi S.J., Lee S.H., Lee K.C., Lee J.I., et al. Nail toxicity after treatment with docetaxel: a prospective analysis in patients with advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology 2007, 37(6):424-428.
7. Hussain S., Anderson D.N., Salvatti M.E., Adamson B., McManus M., Braverman A.S. Onycholysis as a complication of systemic chemotherapy. Cancer 2000, 88(10):2367-2371.
8. Marrs J., Newton S. Chemotherapy-induced nail changes: an unsightly nuisance. Clinical Journal of Oncology Nursing 2004, 8(5):527-528.
9. Minisini A.M., Tosti A., Sobrero A.F., Mansutti M., Piraccini B.M., Sacco C., Puglisi F. Taxane-induced nail changes: incidence, clinical presentation and outcome. Annals of Oncology 2003, 14:333-337.
10. Robinet G., Thomas P., Perol M., Vergnenegre A., Lena H., Taytard A., et al. Phase 2 study of docetaxel in inoperable advanced non-small cell lung cancer. Bulletin du Cancer 2000, 87(3):253-258.
11. Saarinen A., Jekunen A., Halme M., Pyrhonen S., Tamminen K., Boyer Roubille N., Mattson K. A phase 2 trial of docetaxel in advanced non-small cell lung cancer. Anticancer Drugs 1996, 7(8):890-892.
12. Scotté F., Banu E., Medioni J., Levy E., Ebenezer C., Marsan S., et al. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot. Cancer 2008, 112(7):1625-1631.
13. Scotté F., Tourani J.M., Banu E., Peyromaure M., Levy E., Marsan S., et al. Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. Journal of Clinical Oncology 2005, 23(19):4424-4429.
14. Taxol (Paclitaxel) Product Monograph. Bristol-Myers Squibb, Available at: . (accessed 20.02.11.). http://www.bms.com.
15. Taxotere (Docetaxel) Product Monograph. Sanofi-aventis, Available at: . (accessed 20.02.11.). http://www.sanofi-aventis.ca.
16. Wasner G., Hilpert F., Schattschneider J., Binder A., Pfisterer J., Baron R. Docetaxel-induced nail changes-a neurogenic mechanism: a case report. Journal of Neurooncology 2002, 58(2):167-174.
17. Winther D., Saunte D.M., Knap M., Haahr V., Jensen A.B. Nail changes due to docetaxel: a neglected side effect and nuisance for the patient. Supportive Care in Cancer 2007, 15:1191-1197.